Coronary Artery Disease SCIE

国际简称：CORONARY ARTERY DIS 参考译名：冠状动脉疾病

主要研究方向：医学-外周血管病非预警期刊审稿周期：较慢,6-12周

《冠状动脉疾病》(Coronary Artery Disease)是一本由Lippincott Williams and Wilkins Ltd.出版的以医学-外周血管病为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q3 JCR分区
71 年发文量
1.5 IF影响因子
未开放 是否OA
58 H-index
1990 创刊年份
Bimonthly 出版周期
English 出版语言

Coronary Artery Disease welcomes reports of original research with a clinical emphasis, including observational studies, clinical trials, translational research, novel imaging, pharmacology and interventional approaches as well as advances in laboratory research that contribute to the understanding of coronary artery disease. Each issue of Coronary Artery Disease is divided into four areas of focus: Original Research articles, Review in Depth articles by leading experts in the field, Editorials and Images in Coronary Artery Disease. The Editorials will comment on selected original research published in each issue of Coronary Artery Disease, as well as highlight controversies in coronary artery disease understanding and management.

Submitted artcles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Coronary Artery Disease期刊信息

ISSN：0954-6928
出版语言：English
是否OA：未开放
E-ISSN：1473-5830
出版地区：UNITED STATES
是否预警：否
出版商：Lippincott Williams and Wilkins Ltd.
出版周期：Bimonthly
创刊时间：1990
开源占比：0.0657
Gold OA文章占比：10.47%
OA被引用占比：0.0294...
出版国人文章占比：0
出版撤稿占比：0
研究类文章占比：88.73%

Coronary Artery Disease CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

2.5

0.384

0.472

学科类别	分区	排名	百分位
大类：Medicine 小类：Cardiology and Cardiovascular Medicine	Q3	225 / 387	41%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Coronary Artery Disease中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	4区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	4区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	4区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	4区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统	4区

Coronary Artery Disease JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q3	145 / 220	34.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q3	137 / 220	37.95%

Coronary Artery Disease历年数据统计

影响因子

中科院分区

Coronary Artery Disease中国学者发文选摘

1、Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors
Author: Guo, Xuantong; Ma, Lihong

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 1, pp. 66-77. DOI: 10.1097/MCA.0000000000001198
2、Obstructive sleep apnea and cardiovascular events in acute coronary syndrome: a meta-analysis
Author: Tong, Jiangtao; Yu, Qian; Li, Yuan; Du, Jianbo; Qiu, Jian

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 3, pp. 177-184. DOI: 10.1097/MCA.0000000000001207
3、Association between monocyte to high-density lipoprotein ratio and coronary heart disease in US adults in the National Health and Nutrition Examination Surveys 2009-2018
Author: Yan, Shaoyi; Sha, Shuo; Wang, Di; Li, Senjie; Jia, Yongping

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 2, pp. 111-118. DOI: 10.1097/MCA.0000000000001208
4、The relationship between hyperhomocysteinemia and total coronary artery occlusion: a cross-sectional study from Southwest China
Author: Xiao, Kaiyong; Chen, Yuxiong; Xiao, Lian; Sun, Hua; He, Zhongwei; Huang, Guan; Chen, Lvhong; Xv, Lei; Peng, Ling; Li, Juan; Xv, Yuling; Wang, Jianping

Journal: CORONARY ARTERY DISEASE. 2023; Vol. 34, Issue 2, pp. 138-145. DOI: 10.1097/MCA.0000000000001217
5、Comparison between radial and femoral access for percutaneous coronary intervention in left main coronary artery disease: a meta-analysis of nonrandomized trials.
Author: Ye Y¹, Zeng Y.

Journal: Coron Artery Dis. 2019 Mar;30(2):79-86. doi: 10.1097/MCA.0000000000000685.
6、Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3-5 chronic kidney disease undergoing coronary angiography.
Author: Lin LH¹, Liu H^2,¹, Tu Y², Yang Y², Wang B^2,¹, Wang FM², Wu M², Pan MM^2,¹, Tang RN^2,¹, Ma KL^2,¹, Zhang XL^2,¹, Liu BC^2,¹.

Journal: Coron Artery Dis. 2019 Mar;30(2):137-142. doi: 10.1097/MCA.0000000000000692.
7、Serum apelin predicts spontaneous reperfusion of infarct-related artery in patients with ST-segment elevation myocardial infarction.
Author: Ying Z¹, Jiansong Y², Yong W¹, Shubin Q².

Journal: Coron Artery Dis. 2019 Mar;30(2):103-108. doi: 10.1097/MCA.0000000000000702.
8、Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Author: Wang X¹, Li X, Wu H, Li R, Liu H, Wang L, Bai S, Zhang L, Chen T, Liu J, Li Q, Du R.

Journal: Coron Artery Dis. 2019 Jan 5. doi: 10.1097/MCA.0000000000000707. [Epub ahead of print]